FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089734 [Registered on: 27/06/2025] Trial Registered Prospectively
Last Modified On: 26/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study to compare the results of Kuberaksha Vati and Dashmoola Taila Matra Basti in patients having pain during menstruation  
Scientific Title of Study   A comparative clinical study to evaluate the efficacy of Kuberaksha vati and Dashmoola Taila Matra Basti in the management of Udavartini yonivyapad with special reference to primary dysmenorrhea. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shubhi Mishra  
Designation  MS Scholar ( Prasuti Tantra evum Stri Roga) 
Affiliation  State Ayurvedic College and Hospital, Tulsidas marg, Turiyaganj, Lucknow 
Address  PG Department of Prasuti Tantra Evum Stri Roga ,State Ayurvedic College and Hospital, Tulsidas marg, Turiyaganj ,Lucknow, Uttar pradesh, India

Lucknow
UTTAR PRADESH
226004
India 
Phone  7080932612  
Fax    
Email  mshubhi71@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shikha Sharma  
Designation  Lecturer  
Affiliation  State Ayurvedic College and Hospital, Tulsidas marg, Turiyaganj, Lucknow 
Address  PG Department of Prasuti Tantra Evum Stri Roga ,State Ayurvedic College and Hospital, Tulsidas marg, Turiyaganj ,Lucknow, Uttar pradesh, India

Lucknow
UTTAR PRADESH
226004
India 
Phone  8743976379  
Fax    
Email  drshikhasharma1982@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shubhi Mishra  
Designation  MS Scholar ( Prasuti Tantra evum Stri Roga) 
Affiliation  State Ayurvedic College and Hospital, Tulsidas marg, Turiyaganj, Lucknow 
Address  PG Department of Prasuti Tantra Evum Stri Roga ,State Ayurvedic College and Hospital, Tulsidas marg, Turiyaganj ,Lucknow, Uttar pradesh, India

Lucknow
UTTAR PRADESH
226004
India 
Phone  7080932612  
Fax    
Email  mshubhi71@gmail.com  
 
Source of Monetary or Material Support  
State Ayurvedic College and Hospital ,Tulsidas marg, Turiyaganj, Lucknow, Uttar Pradesh, India 226004 
 
Primary Sponsor  
Name  State Ayurvedic College and Hospital , Tulsidas marg, Turiyaganj ,Lucknow , Uttar Pradesh ,India  
Address  PG Department of Prasuti Tantra Evum Stri Roga ,State Ayurvedic College and Hospital ,Tulsidas marg, Turiyaganj, Lucknow, Uttar pradesh, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shubhi Mishra   State Ayurvedic College and Hospital, Tulsidas marg,Turiyaganj, Lucknow  PG Department of Prasuti Tantra evum Stri Roga, State Ayurvedic College and Hospital, Tulsidas marg,Turiyaganj, Lucknow
Lucknow
UTTAR PRADESH 
7080932612

mshubhi71@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Office of Institutional Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kuberaksha Vati, Reference: Brihat Nighantu Ratnakar Shool Rogadhikar, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Lukewarm water), Additional Information: dose- 2 tablets BD 250 mg each orally for 3 consecutive months.
2Comparator ArmDrugClassical(1) Medicine Name: Dashmoola taila matra basti, Reference: Charak Samhita Chikitsasthan 30/110-111, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: Per rectal 7 days before the expected date of menses
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  1.female patient of age 16 to 35 years.
2.Patient suffering from pain during mensuration for more than 3 consecutive cycle.
3.Patient coming with chief complaint of pain during menses with or without associated symptoms.
4. Patient willing and able to participate in study.  
 
ExclusionCriteria 
Details  1.Female patients age below 16 years and above 35 years of age.
2.Patients with any identifiable pelvic pathology like fibroids, adenomyosis, endometriosis, PID, UTI etc.
3.Patients using IUD /oral contraceptive pills.
4.Patient have H/O hypothyroidism and hyperthyroidism with DUB .
5.Patients with systemic disorders like Tuberculosis, Hypertension, Diabetes mellitus, anemia etc.
6.Patient not willing for trial.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.To evaluate the efficacy of Kuberaksha vati and Dashmoola taila matra basti in the management of udavartini yonivyapad.
2.To compare the efficacy of Kuberaksha vati and Kuberaksha vati with Dashmoola Taila Matra Basti. 
1.after 4 weeks
2.after 4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1.Conceptual Study of Udavartini Yonivyapada.
2.To find out safe & potent drug for Udavartini Yonivyapada.
3.Decrease in pain during menses.
4.reduction in associated menstrual problems.
5.To evaluate any adverse effects associated with treatment. 
1.after 4 weeks
2.after 4 weeks 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   14/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a Randomised, comparative clinical study Phase 2 Parallel group trial. Comparing the efficacy of Kuberaksha vati and Dashmoola taila Matra Basti in cases of Udavartini Yonivyapad for 3 months in 40 patients. The patient fulfilling the clinical criteria for diagnosis of Udavartini Yonivyapad will be randomly selected from OPD/IPD of state Ayurvedic College and Hospital, Lucknow and referred cases from other hospitals. A careful history, physical examination and necessary investigation will be performed. Further patient divided into two groups, Group-A- In this group patients will be treated with Kuberaksha vati orally 2 tabs BD (250 mg each) with lukewarm water after meal for the period of 3 months. Group-B- In this group patients will be treated with Kuberaksha vati orally 2 tabs BD (250 mg each) with lukewarm water after meal for the period of 3 months along with Dashmoola taila Matra Basti per rectal in the dose of 60 ml for the period of 7 days before the expected date of menses. Follow up period will be 30 days after the completion of trial. 
Close